The Effect of Latanoprostene Bunod 0.024% on Optical Coherence Tomography Angiography in Newly Diagnosed Open Angle Glaucoma
In conclusion, treatment with LBN ophthalmic solution 0.024% reduced IOP by an average of 29.9% and 31.8% in patients with POAG and PXG, respectively, and improved VD in different quadrants in all slabs. Therefore, the importance of LBN in the treatment of glaucoma is likely to be that it increases macular microcirculation, possibly through NO, independent of its IOP-reducing effect.
Authors
- Zeki Baysal (ORCID: https://orcid.org/0000-0002-5223-4365)
- Gamze Yıldırım Biçer (ORCID: https://orcid.org/0000-0003-3058-6308)
- Ömer Özer (ORCID: https://orcid.org/0000-0003-0329-0931)
- Levent Doğan (ORCID: https://orcid.org/0000-0001-7924-7919)
Institutions
- Center for Science in the Public Interest (United States) (US)
- Niğde Ömer Halisdemir Üniversitesi (TR)
- Thales (Australia) (AU)
- Seva Mandir (IN)
Publication Details
- Journal
- Journal of Glaucoma
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1097/ijg.0000000000002520
- Citations
- 1
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.54